Gaurav Agarwal

Gaurav Agarwal

Active Director Director DIN 07640426
DIN 07640426 First appointment Oct 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value •••• Premium profile

About Gaurav Agarwal

Data last updated:

Gaurav Agarwal is a Director at Rebound Pharma Private Limited (since 2016). The company operates in Pharma. Rebound Pharma Private Limited reported revenue of ₹79.2 Lakh (FY 2021).

DIN 07640426
Primary Designation Director
Industry Pharma
First Appointment 19 Oct 2016
Oldest Company Age 12 yrs
Largest company Rebound Pharma Private Limited · ₹79.2 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rebound Pharma Private Limited U52100WB2014PTC202785
Director19 Oct 20162014₹79.2 Lakh (FY 2021)Active

Board colleagues of Gaurav Agarwal

NameDINCompanyDesignation
Sourav Agarwal07068728Rebound Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Rebound Pharma Private Limited
Premium access

Shareholding and investment profile for Gaurav Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Agarwal

Gaurav Agarwal currently holds 1 directorship: Rebound Pharma Private Limited (Director, since 19 Oct 2016, revenue ₹79.2 Lakh (FY 2021)).

Gaurav Agarwal was first appointed on 19 Oct 2016 as Director at Rebound Pharma Private Limited.

The current boards of Gaurav Agarwal's companies include Sourav Agarwal (Rebound Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available